From CNBC.com….
The Food and Drug Administration said Tuesday it is asking states to temporarily halt using Johnson & Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare blood clotting disorder.
The FDA said the recommendation is “out of an abundance of caution.”
“Right now, these adverse events appear to be extremely rare,” the FDA said in a joint statement with the Centers for Disease Control and Prevention. “COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”
Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution.
— U.S. FDA (@US_FDA) April 13, 2021
A White House spokesman referred CNBC to HHS when asked for comment.
All six cases occurred in women between the ages of 18 and 48, with symptoms developing six to 13 days after they received the shot. Doctors typically treat that type of blood clot with heparin but health regulators noted that could be dangerous in this case and recommended a different treatment.